![]() VERI M -C ET AL: "Monoclonal antibodies capable of discriminating the human inhibitory Fc-receptor IIB (CD32B) from the activating Fc-receptor IIA (CD32A): Biochemical, biological and functional characterization", IMMUNOLOGY 200707 GB LNKD- DOI:10.1111/J., vol.BUDDE P V ET AL: "Specificity of CD32 mAb for FcgRIIa, FcgRIIb1 and FcgRIIb2 expressed in transfected mouse B cells and BHK-21 cells" In: SCHLOSSMAN S F ET AL: "Leukocyte Typing V: White Cell Differentiation Antigens", 1995, OXFORD UNIVERSITY PRESS, NEW YORK pages 828-832,.ET AL.: 'Regulated expression and inhibitory function of FcgammaRIIb in human monocytic cells' J. ET AL.: 'Inhibition of the function of the FcgammaRIIB by monoclonal antibody to thymic shared antigen 1, a Ly-6 family antigen' IMMUNOLOGY vol. XU YUANYUAN ET AL: "Fc gamma Rs modulate cytotoxicity of anti-Fas antibodies: implications for agonistic antibody-based therapeutics." JOURNAL OF IMMUNOLOGY (BALTIMORE, MD.SCHUNA A A ET AL: "New drugs for the treatment of rheumatoid arthritis" AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, vol. ![]() FANGER M W ET AL: "Production and Use of Anti-FcR Bispecific Antibodies" IMMUNOMETHODS, vol.KURLANDER R J ET AL: "Comparison of intravenous gamma globulin and a monoclonal anti-Fc receptor antibody as inhibitors of immune clearance in vivo in mice." THE JOURNAL OF CLINICAL INVESTIGATION.MICKLEM K J ET AL: "Different isoforms of human FcRII distinguished by CDw32 antibodies." JOURNAL OF IMMUNOLOGY (BALTIMORE, MD.WEINRICH V ET AL: "Epitope mapping of new monoclonal antibodies recognizing distinct human FcRII (CD32) isoforms" HYBRIDOMA, LIEBERT, NEW YORK, NY, US, vol.Representative: Jaenichen, Hans-Rainer et al International Patent Classification (IPC): A61K 39/395 (2006.01)įCGAMMARIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOFįCGAMMARIIB-SPEZIFISCHE ANTIKÖRPER UND VERFAHREN ZUR VERWENDUNG DAVONĪNTICORPS SPECIFIQUES DU RECEPTEUR FCGAMMARIIB ET PROCEDES D'UTILISATION DE CES ANTICORPSĪT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR
0 Comments
Leave a Reply. |